4Moving Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $14.1M

  • Investors
  • 4

4Moving Biotech General Information

Description

Operator of a biopharmaceutical research firm intended to develop therapies for osteoarthritis patients. The company uses GLP-1 analogs to target low-grade inflammation and integrates advanced artificial intelligence with real-world data to accelerate clinical trial design, enabling the restoration of mobility and improving quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Rue Du Professeur Calmette
  • 59800 Lille
  • France
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1 Rue Du Professeur Calmette
  • 59800 Lille
  • France

4Moving Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4Moving Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 10-Feb-2026 $14.1M Completed Generating Revenue
3. Grant 08-Apr-2025 Completed Generating Revenue
2. Early Stage VC 29-Apr-2021 $2.39M $2.39M Completed Generating Revenue
1. Spin-Off 01-Jan-2020 Completed Generating Revenue
To view 4Moving Biotech’s complete valuation and funding history, request access »

4Moving Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
A Class 40,569 $1.193700 $16.77 $16.77 1x $16.77 6.51%
To view 4Moving Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

4Moving Biotech Patents

4Moving Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025257419-A1 Glp-1 receptor agonist compounds for treating a proliferative synovial disorder Pending 13-Jun-2024
WO-2025219601-A1 New glp-1 receptor agonists for the treatment of joint diseases Pending 18-Apr-2024
AU-2022300340-A1 Pharmaceutical compositions comprising glp-1r agonists Pending 23-Jun-2021
CA-3223710-A1 Pharmaceutical compositions comprising glp-1r agonists Pending 23-Jun-2021
EP-4108252-A1 Pharmaceutical compositions comprising glp-1r agonists Inactive 23-Jun-2021 A61K38/26
To view 4Moving Biotech’s complete patent history, request access »

4Moving Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

4Moving Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
France 2030 Government
4P-Pharma PE-Backed Company Minority
Bpifrance Sovereign Wealth Fund
SATT Lutech Accelerator/Incubator Minority
To view 4Moving Biotech’s complete investors history, request access »

4Moving Biotech FAQs

  • When was 4Moving Biotech founded?

    4Moving Biotech was founded in 2020.

  • Where is 4Moving Biotech headquartered?

    4Moving Biotech is headquartered in Lille, France.

  • What is the size of 4Moving Biotech?

    4Moving Biotech has 8 total employees.

  • What industry is 4Moving Biotech in?

    4Moving Biotech’s primary industry is Biotechnology.

  • Is 4Moving Biotech a private or public company?

    4Moving Biotech is a Private company.

  • What is 4Moving Biotech’s current revenue?

    The current revenue for 4Moving Biotech is .

  • How much funding has 4Moving Biotech raised over time?

    4Moving Biotech has raised $16.5M.

  • Who are 4Moving Biotech’s investors?

    France 2030, 4P-Pharma, Bpifrance, and SATT Lutech have invested in 4Moving Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process